title: Is there a role for high-dose methylprednisolone in the treatment of hepatic regimen-related toxicity?
authors.forename: K L
authors.initials: KL
authors.lastname: Hennenfent
authors.forename: K M
authors.initials: KM
authors.lastname: Augustin
authors.forename: J F
authors.initials: JF
authors.lastname: Dipersio
authors.forename: H
authors.initials: H
authors.lastname: Khoury
mesh_terms: D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001663:Bilirubin / Q000097:blood; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000401:mortality; D005260:Female; D006801:Humans; D006932:Hyperbilirubinemia / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D008107:Liver Diseases / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D008111:Liver Function Tests / Q000379:methods; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage*; D008875:Middle Aged; D012189:Retrospective Studies; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
chemical_list: D000893:Anti-Inflammatory Agents; D001663:Bilirubin; D008775:Methylprednisolone